Lisa L. von Moltke
Department of Pharmacology and Experimental Therapeutics
Tufts University School of Medicine
Boston
MA 02111
USA
Name/email consistency: high
- Interaction of triazolam and ketoconazole in P-glycoprotein-deficient mice. von Moltke, L.L., Granda, B.W., Grassi, J.M., Perloff, M.D., Vishnuvardhan, D., Greenblatt, D.J. Drug Metab. Dispos. (2004)
- Inhibition of human cytochromes P450 by components of Ginkgo biloba. von Moltke, L.L., Weemhoff, J.L., Bedir, E., Khan, I.A., Harmatz, J.S., Goldman, P., Greenblatt, D.J. J. Pharm. Pharmacol. (2004)
- Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. von Moltke, L.L., Greenblatt, D.J., Giancarlo, G.M., Granda, B.W., Harmatz, J.S., Shader, R.I. Drug Metab. Dispos. (2001)
- Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole. von Moltke, L.L., Durol, A.L., Duan, S.X., Greenblatt, D.J. Eur. J. Clin. Pharmacol. (2000)